RxDoctor Payments Data

Adam Houg, MD

Family Medicine · van Wert, OHNPI 1326039561

Payments from drug & device makers

$428in general payments, 2019–2025

Across 24 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$135
  • Medtronic$90
  • GSK$59
  • Pfizer$29
  • Axsome Therapeutics, Inc.$20
  • Optos, Inc.$16
  • plus $79 from 6 others

What the payments were for

  • Food & beverage$41296%
  • Entertainment$164%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$428 in reported general payments places this provider in the 50th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$148,449
Medicare patients
332
Services billed
2,186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$80,375
TrulicityDulaglutide51$58,386
XareltoRivaroxaban65$45,945
MounjaroTirzepatide35$38,840
EliquisApixaban24$17,029
RybelsusSemaglutide12$13,277
Breo ElliptaFluticasone/Vilanterol28$11,613
MyrbetriqMirabegron28$10,882
Depakote ErDivalproex Sodium13$9,191
PaxlovidNirmatrelvir/Ritonavir30$8,560
Tresiba Flextouch U-100Insulin Degludec11$5,857
Memantine Hcl ErMemantine Hcl21$5,668
BelsomraSuvorexant13$5,462
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$5,041
FarxigaDapagliflozin Propanediol13$4,269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$13$97,22686 claims
Novo NordiskOzempic, Rybelsus$14$93,65170 claims
Johnson & JohnsonXarelto$12$45,94565 claims
PfizerEliquis, Paxlovid$29$25,58854 claims
GSKBreo Ellipta$59$11,61328 claims
AbbVieLumigan$135$3,66214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in van Wert

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →